The Digital Future is Now: Making Patient Choice a Reality

The industry is at a pivotal point in drug development and DCTs. Many sponsors are embracing DCT strategies, but there is a clear need to move away from individual point systems and disconnected data flow to a scalable, cohesive approach to truly achieve the next level of drug development speed.

By focusing on scaling their approach to implementing digital capabilities, sponsors can ensure long-term success and achieve a positive ROI, while finally giving patients the flexibility in choice we’ve only just talked about. But to achieve scale, digital strategies need to be embedded early into the pipeline, requiring the creation of standardized processes and an ecosystem of partners who work together to achieve a common goal.

Watch the on-demand panel discussion between Medable, Syneos, Illingworth and Veeva, moderated by Gilead, as they discuss how the next generation of clinical development is now.

With more than 18 years in the pharmaceutical industry and a doctorate in pharmacy, Nicole Sheetz is known for operational leadership.

Sam Bavery is the Senior Director of Strategy & Growth at Medable.

Juliet Hulse is the Executive Director of Global RN Strategy and Patient Advocacy, at Illingworth Research, a Syneos Health company.

Claire Riches is an industry veteran with over 25 years of experience in the clinical, pre/post approval and commercial arena.

As Vice President, Strategy Vault CDMS, Richard is responsible for establishing Vault CDMS as the best in class solution.

Save the Date!